Jane Street’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,489
| Closed | -$1.07M | – | 6157 |
|
|
2025
Q1 | $1.07M | Buy |
27,489
+23,771
| +639% | +$929K | ﹤0.01% | 2967 |
|
|
2024
Q4 | $201K | Sell |
3,718
-4,210
| -53% | -$228K | ﹤0.01% | 5090 |
|
|
2024
Q3 | $400K | Sell |
7,928
-24,296
| -75% | -$1.23M | ﹤0.01% | 4546 |
|
|
2024
Q2 | $1.42M | Sell |
32,224
-57,945
| -64% | -$2.55M | ﹤0.01% | 3192 |
|
|
2024
Q1 | $4.53M | Buy |
90,169
+12,220
| +16% | +$614K | ﹤0.01% | 1386 |
|
|
2023
Q4 | $4.71M | Buy |
77,949
+72,958
| +1,462% | +$4.41M | ﹤0.01% | 1559 |
|
|
2023
Q3 | $284K | Buy |
+4,991
| New | +$284K | ﹤0.01% | 4109 |
|
|
2023
Q2 | – | Sell |
-26,034
| Closed | -$557K | – | 5741 |
|
|
2023
Q1 | $557K | Buy |
+26,034
| New | +$557K | ﹤0.01% | 3552 |
|
|
2022
Q2 | – | Sell |
-65,437
| Closed | -$726K | – | 5993 |
|
|
2022
Q1 | $726K | Buy |
+65,437
| New | +$726K | ﹤0.01% | 3340 |
|